These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26786589)

  • 1. Effectiveness of intratracheal salbutamol in addition to surfactant on the clinical course of newborns with respiratory distress syndrome: a clinical trial.
    Dehdashtian M; Malakian A; Aramesh MR; Mazori A; Aletayeb MH; Shirani A; Bashirnejad S
    Ital J Pediatr; 2016 Jan; 42():6. PubMed ID: 26786589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge.
    Nayeri FS; Esmaeilnia Shirvani T; Aminnezhad M; Amini E; Dalili H; Moghimpour Bijani F
    Acta Med Iran; 2014; 52(8):596-600. PubMed ID: 25149882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome.
    Goudarzi RM; Badiee Z; Sadeghnia A; Barekatain B
    J Res Med Sci; 2023; 28():53. PubMed ID: 37496643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant administration without intubation in preterm infants with respiratory distress syndrome--our experiences.
    Krajewski P; Chudzik A; Strzałko-Głoskowska B; Górska M; Kmiecik M; Więckowska K; Mesjasz A; Sieroszewski P
    J Matern Fetal Neonatal Med; 2015 Jul; 28(10):1161-4. PubMed ID: 25065621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effect of surfactant administration during nasal continuous positive airway pressure with that of nasal continuous positive airway pressure alone on complications of respiratory distress syndrome: a randomized controlled study.
    Nakhshab M; Tajbakhsh M; Khani S; Farhadi R
    Pediatr Neonatol; 2015 Apr; 56(2):88-94. PubMed ID: 25264154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies.
    Aguar M; Cernada M; Brugada M; Gimeno A; Gutierrez A; Vento M
    Acta Paediatr; 2014 Jun; 103(6):e229-33. PubMed ID: 24628379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive duo positive airway pressure ventilation versus nasal continuous positive airway pressure in preterm infants with respiratory distress syndrome: a randomized controlled trial.
    Malakian A; Aramesh MR; Agahin M; Dehdashtian M
    BMC Pediatr; 2021 Jul; 21(1):301. PubMed ID: 34229655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
    J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of three kinds of non-invasive positive pressure ventilation as a primary mode of ventilation in premature infants with respiratory distress syndrome: a randomized controlled trial].
    Gao X; Yang B; Hei M; Cui X; Wang J; Zhou G; Qu S
    Zhonghua Er Ke Za Zhi; 2014 Jan; 52(1):34-40. PubMed ID: 24680406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant therapy in premature babies: SurE or InSurE.
    Jena SR; Bains HS; Pandita A; Verma A; Gupta V; Kallem VR; Abdullah M; Kawdiya A; On Behalf Of Sure Group
    Pediatr Pulmonol; 2019 Nov; 54(11):1747-1752. PubMed ID: 31424177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial.
    Reininger A; Khalak R; Kendig JW; Ryan RM; Stevens TP; Reubens L; D'Angio CT
    J Perinatol; 2005 Nov; 25(11):703-8. PubMed ID: 16163369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery.
    Pinheiro JM; Santana-Rivas Q; Pezzano C
    J Perinatol; 2016 Mar; 36(3):196-201. PubMed ID: 26633145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung recruitment improves the efficacy of intubation-surfactant-extubation treatment for respiratory distress syndrome in preterm neonates, a randomized controlled trial.
    Yang Y; Yan W; Ruan M; Zhang L; Su J; Deng H; Li M
    BMC Pediatr; 2022 Jan; 22(1):14. PubMed ID: 34980047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early nasal continuous positive airway pressure versus INSURE in VLBW neonates.
    Saianda A; Fernandes RM; Saldanha J
    Rev Port Pneumol; 2010; 16(5):779-95. PubMed ID: 20927494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of INSURE during nasal CPAP in preterm infants with respiratory distress syndrome.
    Leone F; Trevisanuto D; Cavallin F; Parotto M; Zanardo V
    Minerva Pediatr; 2013 Apr; 65(2):187-92. PubMed ID: 23612264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial.
    Escobedo MB; Gunkel JH; Kennedy KA; Shattuck KE; Sánchez PJ; Seidner S; Hensley G; Cochran CK; Moya F; Morris B; Denson S; Stribley R; Naqvi M; Lasky RE;
    J Pediatr; 2004 Jun; 144(6):804-8. PubMed ID: 15192630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early routine versus late selective surfactant in preterm neonates with respiratory distress syndrome on nasal continuous positive airway pressure: a randomized controlled trial.
    Kandraju H; Murki S; Subramanian S; Gaddam P; Deorari A; Kumar P
    Neonatology; 2013; 103(2):148-54. PubMed ID: 23235135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of inhalation of pulmonary surfactant using vibrating mesh nebulizers combined with nasal continuous positive airway pressure in the treatment of neonatal respiratory distress syndrome].
    Gao Y; Chen X; Zhang Z; Qu S; Sang X; Wu Y; Zhou R; Peng W; Chen Y; Wang Y; Zhuo F; Chen L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jan; 34(1):80-84. PubMed ID: 35307066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.